Stockscreener 앱 받기
2.15
0.47%
0.010
시간 외 거래:
2.15
전일 마감가:
$2.14
열려 있는:
$2.14
하루 거래량:
252.91K
Relative Volume:
2.07
시가총액:
$93.81M
수익:
$106.79M
순이익/손실:
$-8.73M
주가수익비율:
-16.54
EPS:
-0.13
순현금흐름:
$10.81M
1주 성능:
-12.24%
1개월 성능:
-12.96%
6개월 성능:
-36.20%
1년 성능:
-49.77%
1일 변동 폭
$2.12
$2.24
1주일 범위
$2.12
$2.45
52주 변동 폭
$2.12
$5.56
Harvard Bioscience Inc Stock (HBIO) Company Profile
명칭
Harvard Bioscience Inc
전화
(508) 893-8999
주소
84 OCTOBER HILL RD, HOLLISTON, MA
HBIO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| HBIO | 2.15 | 93.81M | 106.79M | -8.73M | 10.81M | -0.13 |
| ISRG | 531.64 | 190.09B | 7.87B | 2.24B | 586.00M | 4.25 |
| BDX | 224.10 | 65.14B | 20.18B | 1.73B | 3.07B | 5.51 |
| ALC | 85.81 | 42.44B | 9.76B | 1.16B | 665.00M | 0.72 |
| RMD | 239.42 | 34.99B | 4.81B | 1.11B | 1.35B | 6.16 |
| WST | 307.21 | 22.29B | 2.88B | 499.60M | 321.60M | 7.41 |
Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-03-10 | 업그레이드 | The Benchmark Company | Speculative Buy → Buy |
| 2021-01-07 | 업그레이드 | The Benchmark Company | Speculative Buy → Buy |
| 2020-12-09 | 개시 | Northland Capital | Outperform |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2019-07-08 | 다운그레이드 | Janney | Buy → Neutral |
| 2018-01-24 | 재확인 | Janney | Buy |
| 2018-01-23 | 재확인 | The Benchmark Company | Buy |
| 2016-11-17 | 개시 | Singular Research | Buy |
| 2015-07-28 | 개시 | The Benchmark Company | Buy |
모두보기
Harvard Bioscience Inc 주식(HBIO)의 최신 뉴스
Harvard Bioscience, Inc. (NASDAQ:HBIO) Short Interest Up 13.8% in October - MarketBeat
Ayla Majid becomes first South Asian ACCA president - The Accountant Online
Harvard Bioscience (HBIO) Stock Drops Amid Industry Downturn - GuruFocus.com
272 Capital LP Increases Stake in Harvard Bioscience Inc - GuruFocus.com
HBIO stock touches 52-week low at $2.29 amid market challenges - Investing.com India
Harvard Bioscience (HBIO) Stock Dips Amid Market Volatility - GuruFocus.com
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q3 2024 Earnings Call Transcript - Insider Monkey
Harvard Bioscience Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
Harvard Bioscience (HBIO) Stock Surges with Positive Analyst Rat - GuruFocus.com
Harvard Bioscience Inc (HBIO) Quarterly 10-Q Report - Quartzy
SEC Form 10-Q filed by Harvard Bioscience Inc. - Quantisnow
Harvard Bioscience Inc (HBIO) Q3 2024 Earnings Call Highlights: Navigating Challenges and ... By GuruFocus - Investing.com Canada
Harvard Bioscience: Q3 Earnings Snapshot - CT Insider
Harvard Bioscience, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
3 Promising US Penny Stocks With At Least $100M Market Cap - Simply Wall St
Harvard Bioscience Inc Reports Q3 2024 Revenue of $22.0M, Misses Estimates; EPS Loss of $0.11 - GuruFocus.com
Harvard Bioscience : Q32024 HBIO Quarterly Earnings Presentation - Marketscreener.com
Harvard Bioscience Announces Third Quarter 2024 Financial Results - GlobeNewswire
Harvard Bioscience Inc (HBIO) Q3 2024 Earnings Report Preview: W - GuruFocus.com
Harvard Bioscience Inc (HBIO) Q3 2024 Earnings Report Preview: What To Expect - Yahoo Finance
Is It Too Late To Consider Buying Harvard Bioscience, Inc. (NASDAQ:HBIO)? - Yahoo Finance
Zacks Industry Outlook Highlights Mettler-Toledo International and Harvard Bioscience - Yahoo Finance
Harvard Bioscience (HBIO) Set to Announce Earnings on Thursday - MarketBeat
Moolec Science (MLEC) versus Its Rivals Head-To-Head Comparison - Defense World
Chegg, Inc. (NYSE:CHGG) Receives Consensus Rating of “Reduce” from Brokerages - Defense World
Harvard Bioscience Schedules Third Quarter 2024 Earnings Conference Call for November 7, 2024 at 8:00 AM ET - The Manila Times
2 Instruments Stocks to Watch From a Challenging Industry - Yahoo Finance
HBIO stock touches 52-week low at $2.31 amid market challenges - Investing.com India
Electroporation Instruments Market Analysis by Trends, - openPR
HBIO stock touches 52-week low at $2.33 amid market challenges - Investing.com Australia
Harvard Bioscience Inc (HBIO) Q2 2024 Earnings Call Highlights: Navigating Challenges with Strategic Initiatives - GuruFocus.com
Harvard Bioscience Inc (HBIO) Q2 2024 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
Laboratory Centrifuge Market Innovations Investigated by Insights: Technological Advancements and Market Gr... - WhaTech
Institutional owners may take dramatic actions as Harvard Bioscience, Inc.'s (NASDAQ:HBIO) recent 12% drop adds to one-year losses - Simply Wall St
Annual Sustainability Report - Harvard University
Editas trades part of Vertex CRISPR therapy licencing rights deal for $57m - Pharmaceutical Technology
HBIO stock touches 52-week low at $2.49 amid market challenges By Investing.com - Investing.com South Africa
HBIO stock touches 52-week low at $2.49 amid market challenges - Investing.com
HBIO Stock Drops Amidst Market Fluctuations - GuruFocus.com
Harvard Biosciences to Appear at Chicago Meeting - Baystreet.ca
Harvard Bioscience to Showcase Innovative Technologies at Society for Neuroscience (SfN) Annual Meeting 2024 - The Manila Times
SPDR S&P Retail ETF (NYSEARCA:XRT) Stock Position Decreased by Renaissance Technologies LLC - Defense World
Compugen Ltd. (NASDAQ:CGEN) Shares Sold by Renaissance Technologies LLC - Defense World
Renaissance Technologies LLC Sells 11,300 Shares of SEACOR Marine Holdings Inc. (NYSE:SMHI) - Defense World
Harvard Bioscience Inc (HBIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.70%
3.32%
자본화:
|
볼륨(24시간):